0001062993-23-022626.txt : 20231215 0001062993-23-022626.hdr.sgml : 20231215 20231215162136 ACCESSION NUMBER: 0001062993-23-022626 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231213 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NEUPERT PETER M CENTRAL INDEX KEY: 0001237566 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 231490651 MAIL ADDRESS: STREET 1: 13920 SE EASTGATE WAY STREET 2: STE 300 CITY: BELLEVUE STATE: WA ZIP: 98005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1165 EASTLAKE AVE E CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-12-13 0001478320 Adaptive Biotechnologies Corp ADPT 0001237566 NEUPERT PETER M C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST SEATTLE WA 98109 1 0 0 0 0 Common Stock 2023-12-13 4 M 0 100000 0.84 A 122968 D Stock Option (right to buy) .84 2023-12-13 4 M 0 100000 0 D 2023-12-23 Common Stock 100000 0 D The option vested with respect to 1/4 of the Shares under the grant on the year anniversary of December 23, 2013 and with respect to 1/48 of the Shares under the grant monthly thereafter. /s/ Peter M Neupert by Stacy L Taylor, Attorney-in-Fact 2023-12-15